ScholarIQanswers from OpenAlex & ORCID
Edward S. Kim
ResearcherPublications, citations & collaboration network
Edward S. Kim is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Edward S. Kim have?
ScholarIQindexed works
Edward S. Kim has 533 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Edward S. Kim have?
ScholarIQcitation count
Edward S. Kim has 18,926 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Edward S. Kim?
ScholarIQh-index
Edward S. Kim has an h-index of 67 in OpenAlex.
What is the i10-index of Edward S. Kim?
ScholarIQi10-index
Edward S. Kim has an i10-index of 163 in OpenAlex.
What is the ORCID of Edward S. Kim?
ScholarIQorcid
The ORCID for Edward S. Kim is on the source record.
What is the OpenAlex record for Edward S. Kim?
ScholarIQopenalex
The OpenAlex for Edward S. Kim is on the source record.
What are the most-cited papers on Edward S. Kim?
ScholarIQmost cited works
An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance
Lauren A. Byers, Lixia Diao, Jing Wang, Pierre Saintigny, Luc Girard, Michael Peyton, Li Shen, You-Hong Fan, Uma Giri, Praveen K. Tumula, Monique B. Nilsson, Jayanthi Gudikote, Hai T. Tran, Robert J. Cardnell, David J. Bearss, Steven L. Warner, Jason M. Foulks, Steven B. Kanner, Varsha Gandhi, Nancy Krett, Steven T. Rosen, Edward S. Kim, Roy S. Herbst, George R. Blumenschein, J. Jack Lee, Scott M. Lippman, K. Kian Ang, Gordon B. Mills, Waun Ki Hong, John N. Weinstein, Ignacio I. Wistuba, Kevin R. Coombes, John D. Minna, John V. Heymach
The BATTLE Trial: Personalizing Therapy for Lung Cancer
Edward S. Kim, Roy S. Herbst, Ignacio I. Wistuba, J. Jack Lee, George R. Blumenschein, Anne S. Tsao, David J. Stewart, Marshall E. Hicks, Jeremy J. Erasmus, Sanjay Gupta, Christine Alden, Suyu Liu, Ximing Tang, Fadlo R. Khuri, Hai T. Tran, Bruce E. Johnson, John V. Heymach, Li Mao, Frank V. Fossella, Merrill S. Kies, Vassiliki A. Papadimitrakopoulou, Suzanne E. Davis, Scott M. Lippman, Waun Ki Hong
Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase–Positive Non–Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial
Dong‐Wan Kim, Marcello Tiseo, Myung‐Ju Ahn, Karen L. Reckamp, Karin Holmskov Hansen, Sang‐We Kim, Rudolf M. Huber, Howard West, Harry J.M. Groen, Maximilian J. Hochmair, Natasha B. Leighl, Scott Gettinger, Corey J. Langer, Luis G. Paz-Ares Rodríguez, Egbert F. Smit, Edward S. Kim, William M. Reichmann, Frank G. Haluska, David Kerstein, D. Ross Camidge
Effect of KRAS Oncogene Substitutions on Protein Behavior: Implications for Signaling and Clinical Outcome
Nathan T. Ihle, Lauren A. Byers, Edward S. Kim, Pierre Saintigny, J. Jack Lee, George R. Blumenschein, Anne S. Tsao, Suyu Liu, Jill E. Larsen, Jing Wang, Lixia Diao, Kevin R. Coombes, Lu Chen, Shuxing Zhang, Mena Abdelmelek, Ximing Tang, Vassiliki A. Papadimitrakopoulou, John D. Minna, Scott M. Lippman, Waun Ki Hong, Roy S. Herbst, Ignacio I. Wistuba, John V. Heymach, Garth Powis
Relationship Between Tumor Size and Survival in Non–Small-Cell Lung Cancer (NSCLC): An Analysis of the Surveillance, Epidemiology, and End Results (SEER) Registry
Jianjun Zhang, Kathryn A. Gold, Heather Lin, Stephen G. Swisher, Yan Xing, J. Jack Lee, Edward S. Kim, William N. William